Publications by authors named "Nathaniel McClean"

Claim this Profile
F
First-in-class mitogen-activated protein kinase (MAPK) p38α: MAPK-activated protein kinase 2 dual signal modulator with anti-inflammatory and endothelial-stabilizing properties.
Mohan E Tulapurkar, Kari Ann Shirey, Katerina Lugkey, Wendy Luo, Ritu Lal, Nathaniel McClean

J Pharmacol Exp Ther· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progress in the development of kinase inhibitors for treating asthma and COPD.
Nathaniel McClean, Jeffery D Hasday, Paul Shapiro

Adv Pharmacol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis